BamSEC and AlphaSense Join Forces
Learn More

Intellia Therapeutics Inc.

NASDAQ: NTLA    
Share price (9/5/25): $12.06    
Market cap (9/5/25): $1.295 billion
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 24 pages Third Amended and Restated By-Laws of Intellia Therapeutics, Inc
12/34/56
EX-3.1
from 10-K 14 pages Second Amended and Restated Certificate of Incorporation of Intellia Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 4 pages Certificate of Second Amendment of Second Amended and Restated Certificate of Incorporation of Intellia Therapeutics, Inc
12/34/56
EX-3.1
from 10-K 11 pages Second Amended and Restated Certificate of Incorporation of Intellia Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 3 pages Certificate of Amendment of Second Amended and Restated Certificate of Incorporation of Intellia Therapeutics, Inc
12/34/56
EX-3.1
from 10-Q 22 pages Second Amended and Restated By-Laws of Intellia Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 1 page Amendment to the Second Amended and Restated By-Laws of Intellia Therapeutics, Inc
12/34/56
EX-3.2
from 8-K 23 pages Second Amended and Restated By-Laws of Intellia Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 7 pages Second Amended and Restated Certificate of Incorporation of Intellia Therapeutics, Inc
12/34/56
EX-3.1
from S-1/A 29 pages Amended and Restated Certificate of Incorporation of Intellia Therapeutics, Inc
12/34/56
EX-3.4
from S-1 23 pages Second Amended and Restated By-Laws of Intellia Therapeutics, Inc
12/34/56
EX-3.3
from S-1 15 pages Amended and Restated By-Laws of Intellia Therapeutics, Inc
12/34/56
EX-3.2
from S-1 7 pages Second Amended and Restated Certificate of Incorporation of Intellia Therapeutics, Inc
12/34/56
EX-3.1
from S-1 26 pages Amended and Restated Certificate of Incorporation of Intellia Therapeutics, Inc
12/34/56
EX-3
from DRS 15 pages Amended and Restated By-Laws of Intellia Therapeutics, Inc
12/34/56
EX-3
from DRS 26 pages Amended and Restated Certificate of Incorporation of Intellia Therapeutics, Inc
12/34/56